| (+)-Columbianetin |
|
|
|
|
|
99.04% |
| L-Citronellol |
|
|
|
|
|
99.84% |
| (3S)-Tanzisertib hydrochloride |
|
|
|
|
|
|
| Cuspin-1 |
|
|
|
|
|
|
| (7R)-Eras-4001 |
|
|
|
|
|
|
| (E/Z)-CLH304a |
|
|
|
|
|
|
| (R)-MK-8353 |
|
|
|
|
|
96.59% |
| (R)-VX-11e |
|
|
|
|
|
98.73% |
| (Rac)-AAA |
|
|
|
|
|
|
| (rel)-AR234960 |
|
|
|
|
|
98.95% |
| (S)-Veludacigib |
|
|
|
|
|
99.43% |
| (S,R,S)-BBO-11818 |
|
|
|
|
|
|
| 1,3,5-Tricaffeoylquinic acid |
|
|
|
|
|
|
| Tetramethyluric acid |
|
|
|
|
|
99.63% |
| 10-Hydroxy-2-decenoic acid |
|
|
|
|
|
99.93% |
| 12(S)-HETE |
|
|
|
|
|
99.10% |
| 12(S)-HETE-d8 |
|
|
|
|
|
|
| 18:0-22:6 DG |
|
|
|
|
|
99% |
| 2"-O-Galloylhyperin |
|
|
|
|
|
99.57% |
| 2"-O-Galloylhyperin (Standard) |
|
|
|
|
|
|
| 2,3,5,4'-Tetrahydroxystilbene 2-O-β-D-glucoside |
|
|
|
|
|
99.91% |
| 2,5-Dihydroxyacetophenone |
|
|
|
|
|
99.95% |
| Phenylhydroquinone |
|
|
|
|
|
99.21% |
| 20:4 Lyso PI |
|
|
|
|
|
|
| 24-O-Acetyllycoclavanol |
|
|
|
|
|
|
| Alisol A 24-acetate |
|
|
|
|
|
98.0% |
| 264RAD |
|
|
|
|
|
|
| 26-Deoxyactein |
|
|
|
|
|
99.76% |
| 3′,4′,7-Trihydroxyflavone |
|
|
|
|
|
99.04% |
| 3'-Methoxy-4'-nitroflavone |
|
|
|
|
|
|
| Gallic aldehyde |
|
|
|
|
|
99.92% |
| 4′-Demethylnobiletin |
|
|
|
|
|
99.69% |
| 4'-O-Methylbavachalcone |
|
|
|
|
|
99.64% |
| 4-Hydroxychalcone |
|
|
|
|
|
99.29% |
| 4-Methylbenzylidene camphor |
|
|
|
|
|
99.87% |
| 5-Methoxytryptophol |
|
|
|
|
|
99.95% |
| 5-O-Methylvisammioside |
|
|
|
|
|
99.90% |
| 6'-BPANeuGc |
|
|
|
|
|
|
| 6'-Sialyllactose |
|
|
|
|
|
99.60% |
| 6'-Sialyllactose sodium |
|
|
|
|
|
98.05% |
| 6,8-Diprenylorobol |
|
|
|
|
|
98.40% |
| 6-Hydroxyflavone |
|
|
|
|
|
99.92% |
| 6-O-Isobutyrylbritannilactone |
|
|
|
|
|
98.34% |
| 6-OAU |
|
|
|
|
|
99.77% |
| 6-Demethoxytangeretin |
|
|
|
|
|
99.37% |
| 7,4'-Dimethoxy-3-hydroxyflavone |
|
|
|
|
|
|
| 7-Methoxy-4H-chromen-4-one-o-carborane |
|
|
|
|
|
|
| 7α,15-Dihydroxydehydroabietic acid |
|
|
|
|
|
|
| 7α-Hydroxycholesterol |
|
|
|
|
|
99.99% |
| 7-Hydroxyflavone |
|
|
|
|
|
99.89% |
| 9(10)-Nitrooleate |
|
|
|
|
|
|
| [Tyr8] Bradykinin |
|
|
|
|
|
99.61% |
| A-582941 |
|
|
|
|
|
|
| A-582941 dihydrochloride |
|
|
|
|
|
99.78% |
| ABD56 |
|
|
|
|
|
|
| AC-P19M |
|
|
|
|
|
|
| ACA-28 |
|
|
|
|
|
99.70% |
| Acesulfame |
|
|
|
|
|
|
| Acetoxycycloheximide |
|
|
|
|
|
|
| AD-35 |
|
|
|
|
|
|
| Adenosine receptor antagonist 7 |
|
|
|
|
|
|
| ADTL-EI1712 |
|
|
|
|
|
|
| AF710B |
|
|
|
|
|
|
| AG01 |
|
|
|
|
|
95.10% |
| AG126 |
|
|
|
|
|
98.0% |
| AGW-11 |
|
|
|
|
|
|
| AHL-7160 |
|
|
|
|
|
|
| AKT-IN-11 |
|
|
|
|
|
|
| AKT-IN-24 |
|
|
|
|
|
|
| Akt/NF-κB/MAPK-IN-1 |
|
|
|
|
|
|
| AKT1-IN-13 |
|
|
|
|
|
|
| AL-8810 |
|
|
|
|
|
99.0% |
| Albanol B |
|
|
|
|
|
99.79% |
| Alcudacigib |
|
|
|
|
|
|
| Alcudacigib TFA |
|
|
|
|
|
99.13% |
| Aloisine A |
|
|
|
|
|
|
| Ambuic acid |
|
|
|
|
|
|
| Amsacrine isethionate |
|
|
|
|
|
|
| Amsacrine lactate |
|
|
|
|
|
|
| AMT-562 |
|
|
|
|
|
|
| AMZ30 |
|
|
|
|
|
99.10% |
| Angiogenesis inhibitor 7 |
|
|
|
|
|
|
| Anti-aging agent 1 |
|
|
|
|
|
98.75% |
| Anti-Big-ET-1 Antibody |
|
|
|
|
|
|
| Anti-IL11 Antibody (X203) |
|
|
|
|
|
98.53% |
| Anti-IL11RA Antibody (X209) |
|
|
|
|
|
97.75% |
| Anti-inflammatory agent 100 |
|
|
|
|
|
|
| Anti-inflammatory agent 116 |
|
|
|
|
|
|
| Anti-inflammatory agent 31 |
|
|
|
|
|
|
| Anti-inflammatory agent 35 |
|
|
|
|
|
99.77% |
| Anti-inflammatory agent 99 |
|
|
|
|
|
|
| Anti-Mouse CD38 Antibody (NIMR5) |
|
|
|
|
|
95.00% |
| Anticancer agent 231 |
|
|
|
|
|
|
| Anticancer agent 301 |
|
|
|
|
|
|
| Anticancer agent 319 |
|
|
|
|
|
|
| Antiproliferative agent-37 |
|
|
|
|
|
98.29% |
| Antitumor agent-122 |
|
|
|
|
|
|
| Apoptosis inducer 35 |
|
|
|
|
|
|
| Apoptosis inducer 55 |
|
|
|
|
|
|
| APS03118 |
|
|
|
|
|
|
| Arnicolide B |
|
|
|
|
|
|
| Arundic Acid |
|
|
|
|
|
98.0% |
| ASN007 |
|
|
|
|
|
99.48% |
| ASN007 benzenesulfonate |
|
|
|
|
|
99.72% |
| ASP2453 |
|
|
|
|
|
98.28% |
| ASTX029 |
|
|
|
|
|
99.86% |
| AT-533 |
|
|
|
|
|
98.38% |
| ATWLPPRAANLLMAAS |
|
|
|
|
|
|
| ATX inhibitor 26 |
|
|
|
|
|
|
| Autotaxin-IN-8 |
|
|
|
|
|
|
| Avatrombopag maleate |
|
|
|
|
|
99.99% |
| Avicin G |
|
|
|
|
|
|
| AX-15836 |
|
|
|
|
|
99.79% |
| AZ14289671 |
|
|
|
|
|
|
| AZA197 |
|
|
|
|
|
98.71% |
| B7-33 |
|
|
|
|
|
99.31% |
| BAY 2476568 |
|
|
|
|
|
99.88% |
| BAY885 |
|
|
|
|
|
99.33% |
| BBO-11818 |
|
|
|
|
|
99.77% |
| Benzyl salicylate |
|
|
|
|
|
99.78% |
| Benzyl salicylate-d4 |
|
|
|
|
|
99.01% |
| Berkeleyacetal C |
|
|
|
|
|
|
| BI-113823 |
|
|
|
|
|
99.23% |
| BI-4732 |
|
|
|
|
|
99.30% |
| BI-836880 |
|
|
|
|
|
|
| Biotin-ERK2 Recombinant Human Active Protein Kinase |
|
|
|
|
|
|
| BIX02188 |
|
|
|
|
|
98.10% |
| BIX02189 |
|
|
|
|
|
99.72% |
| BJ-2302 |
|
|
|
|
|
|
| BMS-986126 |
|
|
|
|
|
|
| BNC-1 |
|
|
|
|
|
|
| Bohemine |
|
|
|
|
|
98.93% |
| Bozepinib |
|
|
|
|
|
|
| BPRCX807 |
|
|
|
|
|
|
| BR103354 |
|
|
|
|
|
|
| Breceptin |
|
|
|
|
|
|
| BRL-44408 |
|
|
|
|
|
|
| BRL-44408 maleate |
|
|
|
|
|
99.0% |
| Brophenexin |
|
|
|
|
|
98.74% |
| Brophenexin free base |
|
|
|
|
|
99.24% |
| Broussonin E |
|
|
|
|
|
98.11% |
| BSI-001 |
|
|
|
|
|
|
| BTX-6654 |
|
|
|
|
|
|
| BTX-6654 formate |
|
|
|
|
|
98.85% |
| BYBC-1 |
|
|
|
|
|
|
| c-Fos-IN-1 |
|
|
|
|
|
97.24% |
| C-VGB3 |
|
|
|
|
|
|
| C11 peptide-1 |
|
|
|
|
|
|
| C16-PAF |
|
|
|
|
|
99.15% |
| C3 sodium |
|
|
|
|
|
|
| CAIX/XII/NAMPT-IN-1 |
|
|
|
|
|
|
| Calactin |
|
|
|
|
|
|
| Candidalysin |
|
|
|
|
|
99.81% |
| Cathepsin G |
|
|
|
|
|
|
| CC-90003 |
|
|
|
|
|
99.50% |
| CDPPB |
|
|
|
|
|
98.01% |
| Cearoin |
|
|
|
|
|
99.09% |
| Cefotetan |
|
|
|
|
|
98.52% |
| Cernuumolide J |
|
|
|
|
|
|
| CG 858-Neg |
|
|
|
|
|
|
| CGP78850 |
|
|
|
|
|
99.47% |
| Chemerin-9 (149-157) |
|
|
|
|
|
99.57% |
| Chemerin-9 (149-157) TFA |
|
|
|
|
|
98.41% |
| Chemerin15 |
|
|
|
|
|
99.65% |
| CHNQD-01281 |
|
|
|
|
|
|
| CHPG |
|
|
|
|
|
99.51% |
| CHPG sodium salt |
|
|
|
|
|
99.57% |
| CK2/ERK8-IN-1 |
|
|
|
|
|
99.0% |
| CKLF1-C27 |
|
|
|
|
|
98.02% |
| CKLF1-C27 TFA |
|
|
|
|
|
|
| CLH304a |
|
|
|
|
|
99.64% |
| CLP-d2 |
|
|
|
|
|
|
| Cm-CATH2 |
|
|
|
|
|
|
| CN009543V |
|
|
|
|
|
99.37% |
| Coelogin |
|
|
|
|
|
|
| Cot-IN-4 |
|
|
|
|
|
|
| Creosol |
|
|
|
|
|
99.82% |
| Creosol-d4 |
|
|
|
|
|
|
| CSF1R-IN-26 |
|
|
|
|
|
|
| Cudraflavone B |
|
|
|
|
|
|
| CXJ-2 |
|
|
|
|
|
|
| D-87503 |
|
|
|
|
|
|
| D-DT/MIF-1-IN-1 |
|
|
|
|
|
|
| Dabogratinib |
|
|
|
|
|
99.90% |
| Dabogratinib |
|
|
|
|
|
|
| DCZ3301 |
|
|
|
|
|
99.73% |
| Degalactotigonin |
|
|
|
|
|
|
| DEL-22379 |
|
|
|
|
|
99.69% |
| Deltafluorine |
|
|
|
|
|
|
| Demethylasterriquinone B1 |
|
|
|
|
|
98.10% |
| Desipramine |
|
|
|
|
|
|
| DETD-35 |
|
|
|
|
|
|
| DGY-09-192 |
|
|
|
|
|
99.50% |
| DL-threo-Dihydrosphingosine |
|
|
|
|
|
|
| DMU-212 |
|
|
|
|
|
99.31% |
| Dodoviscin I |
|
|
|
|
|
|
| DOR agonist 2 |
|
|
|
|
|
|
| DSO-5a |
|
|
|
|
|
|
| DZ2002 |
|
|
|
|
|
99.83% |
| DZX19 |
|
|
|
|
|
|
| Edaxeterkib |
|
|
|
|
|
|
| EF24 |
|
|
|
|
|
99.34% |
| EGFR-IN-113 |
|
|
|
|
|
|
| EGFR-IN-120 |
|
|
|
|
|
|
| EGFR-IN-151 |
|
|
|
|
|
|
| EGFR-IN-173 |
|
|
|
|
|
|
| EGFR-IN-182 |
|
|
|
|
|
|
| EGFR-IN-197 |
|
|
|
|
|
|
| EGFR-IN-201 |
|
|
|
|
|
|
| EGFR-IN-451 |
|
|
|
|
|
|
| EGFR/tubulin-IN-1 |
|
|
|
|
|
|
| Elaidic acid-d17 |
|
|
|
|
|
|
| Elaidic acid-d9 |
|
|
|
|
|
99.0% |
| Elironrasib |
|
|
|
|
|
99.42% |
| Endothelin-1 (1-31) (Human) |
|
|
|
|
|
99.73% |
| Endothelin-1 (1-31) (Human) acetate |
|
|
|
|
|
|
| Endothelin-1 (1-31) (Human) TFA |
|
|
|
|
|
99.79% |
| epi-Eriocalyxin A |
|
|
|
|
|
|
| ERBB agonist-1 |
|
|
|
|
|
99.16% |
| ERK-CLIPTAC |
|
|
|
|
|
|
| ERK-IN-2 |
|
|
|
|
|
|
| ERK-IN-2 free base |
|
|
|
|
|
|
| ERK-IN-4 |
|
|
|
|
|
98.30% |
| ERK1/2 inhibitor 1 |
|
|
|
|
|
99.58% |
| ERK1/2 inhibitor 10 |
|
|
|
|
|
|
| ERK1/2 inhibitor 11 |
|
|
|
|
|
|
| ERK1/2 inhibitor 12 |
|
|
|
|
|
|
| ERK1/2 inhibitor 13 |
|
|
|
|
|
|
| ERK1/2 inhibitor 3 |
|
|
|
|
|
|
| ERK1/2 inhibitor 4 |
|
|
|
|
|
|
| ERK1/2 inhibitor 5 |
|
|
|
|
|
|
| ERK1/2 inhibitor 7 |
|
|
|
|
|
99.00% |
| ERK1/2 inhibitor 8 |
|
|
|
|
|
|
| ERK1/2 inhibitor 9 |
|
|
|
|
|
95.91% |
| ERK2 allosteric-IN-1 |
|
|
|
|
|
|
| ERK2 IN-1 |
|
|
|
|
|
|
| ERK2 IN-5 |
|
|
|
|
|
|
| ERK2-IN-4 |
|
|
|
|
|
99.9% |
| ERK2/p38α MAPK-IN-1 |
|
|
|
|
|
|
| ERK5 ligand-1 |
|
|
|
|
|
|
| ERK5-IN-1 |
|
|
|
|
|
99.55% |
| ERK5-IN-2 |
|
|
|
|
|
98.45% |
| ERK5-IN-3 |
|
|
|
|
|
|
| ERK5-IN-5 |
|
|
|
|
|
99.05% |
| ERK5-IN-6 |
|
|
|
|
|
|
| ERK5-IN-7 |
|
|
|
|
|
|
| Erlotinib-d4 |
|
|
|
|
|
|
| EtDO-P4 |
|
|
|
|
|
99.63% |
| ETI41 |
|
|
|
|
|
|
| ETI60 |
|
|
|
|
|
99.51% |
| ETP-45835 dihydrochloride |
|
|
|
|
|
|
| EUK-189 |
|
|
|
|
|
|
| Evariquinone |
|
|
|
|
|
|
| EVT801 |
|
|
|
|
|
|
| Ferroptosis inducer-7 |
|
|
|
|
|
|
| FGF7p |
|
|
|
|
|
99.34% |
| FGFR-IN-23 |
|
|
|
|
|
|
| Firazorexton |
|
|
|
|
|
99.56% |
| Firazorexton hydrate |
|
|
|
|
|
99.94% |
| FLC-8 |
|
|
|
|
|
|
| FLT3-IN-34 |
|
|
|
|
|
|
| FLT3-IN-36 |
|
|
|
|
|
|
| FLT3-IN-37 |
|
|
|
|
|
|
| FLT3-IN-40 |
|
|
|
|
|
|
| FLT3-IN-41 |
|
|
|
|
|
|
| Fluorofenidone |
|
|
|
|
|
99.78% |
| Fluorofenidone-d3 |
|
|
|
|
|
|
| FQI1 |
|
|
|
|
|
99.11% |
| FR 180204 |
|
|
|
|
|
99.91% |
| FR900359 |
|
|
|
|
|
99.90% |
| FTI-277 |
|
|
|
|
|
|
| FTI-277 TFA |
|
|
|
|
|
|
| Fulipiftide |
|
|
|
|
|
99.38% |
| FYJ-195 |
|
|
|
|
|
|
| FZ1 peptide |
|
|
|
|
|
99.92% |
| G721-0282 |
|
|
|
|
|
99.96% |
| Galloylpaeoniflorin |
|
|
|
|
|
98.30% |
| Ganglioside GM1 (bovine) ammonium |
|
|
|
|
|
98% |
| Ganglioside GM2 |
|
|
|
|
|
98.0% |
| Ganglioside GQ1b (bovine) sodium |
|
|
|
|
|
98% |
| Ganglioside GT1b (bovine) ammonium |
|
|
|
|
|
98% |
| Ganglioside GT1b (porcine) ammonium |
|
|
|
|
|
98% |
| GE1111 |
|
|
|
|
|
95.73% |
| Geranial |
|
|
|
|
|
99.51% |
| Geranylgeranyl pyrophosphate |
|
|
|
|
|
|
| Geranylgeranyl pyrophosphate triammonium |
|
|
|
|
|
95.0% |
| Ginkgo biloba extract |
|
|
|
|
|
|
| GIT1-IN-1 |
|
|
|
|
|
|
| Gluconate-13C6 sodium |
|
|
|
|
|
99.95% |
| Glutathione trisulfide |
|
|
|
|
|
|
| GPR34 receptor antagonist 2 |
|
|
|
|
|
99.26% |
| GPR34 receptor antagonist 3 |
|
|
|
|
|
99.88% |
| GQ127 |
|
|
|
|
|
|
| GRK5-IN-2 |
|
|
|
|
|
99.89% |
| GSK143 |
|
|
|
|
|
|
| GSK143 dihydrochloride |
|
|
|
|
|
99.37% |
| GZD-552 |
|
|
|
|
|
|
| H-Ile-Lys-Val-Ala-Val-OH |
|
|
|
|
|
99.35% |
| HA-1004 |
|
|
|
|
|
99.04% |
| HA-1004 dihydrochloride |
|
|
|
|
|
|
| HA-1004 hydrochloride |
|
|
|
|
|
|
| HDAC6-IN-61 |
|
|
|
|
|
|
| HDB-1 |
|
|
|
|
|
98.02% |
| Heart-homing peptide |
|
|
|
|
|
|
| Hericene A |
|
|
|
|
|
98.84% |
| HIOC |
|
|
|
|
|
99.94% |
| Hirsutenone |
|
|
|
|
|
99.74% |
| Hispidin |
|
|
|
|
|
99.85% |
| HKB99 |
|
|
|
|
|
99.65% |
| HVF18-a3-d |
|
|
|
|
|
|
| HYD-1 |
|
|
|
|
|
|
| Hydrangenol |
|
|
|
|
|
99.62% |
| Hydrostatin-TL1 |
|
|
|
|
|
|
| I-287 |
|
|
|
|
|
99.36% |
| I194496 |
|
|
|
|
|
98.52% |
| IK-595 |
|
|
|
|
|
98.55% |
| IL13Rα2 D1 |
|
|
|
|
|
99.17% |
| Inflachromene |
|
|
|
|
|
99.76% |
| INH2BP |
|
|
|
|
|
|
| Insulin Detemir |
|
|
|
|
|
95% |
| Iruplinalkib |
|
|
|
|
|
99.62% |
| Isoprocurcumenol |
|
|
|
|
|
95.41% |
| Isorhamnetin-3-O-glucoside |
|
|
|
|
|
99.96% |
| Isostrictiniin |
|
|
|
|
|
|
| ITZ-1 |
|
|
|
|
|
|
| JG26 |
|
|
|
|
|
98.14% |
| JWG-045 |
|
|
|
|
|
|
| JWG-071 |
|
|
|
|
|
98.74% |
| JWJ-01-378 |
|
|
|
|
|
|
| K20 |
|
|
|
|
|
|
| K284-6111 |
|
|
|
|
|
99.94% |
| Kanglexin |
|
|
|
|
|
99.65% |
| KBU2046 |
|
|
|
|
|
99.52% |
| KO-947 |
|
|
|
|
|
99.68% |
| KRAS G12C inhibitor 56 |
|
|
|
|
|
|
| KRAS G12C inhibitor 61 |
|
|
|
|
|
|
| KRAS G12C inhibitor 69 |
|
|
|
|
|
|
| KRAS G12C-IN-76 |
|
|
|
|
|
|
| KRAS G12C-IN-77 |
|
|
|
|
|
|
| KRAS G12C-IN-78 |
|
|
|
|
|
|
| KRAS G12D-IN-27 |
|
|
|
|
|
|
| KRAS G12D-IN-30 |
|
|
|
|
|
99.38% |
| KRAS G12D-IN-35 |
|
|
|
|
|
|
| KRAS G12D-IN-36 |
|
|
|
|
|
|
| KRAS G12D-IN-37 |
|
|
|
|
|
|
| KRAS inhibitor-27 |
|
|
|
|
|
|
| KRAS-IN-43 |
|
|
|
|
|
|
| KRAS-IN-51 |
|
|
|
|
|
|
| KRAS-IN-58 |
|
|
|
|
|
|
| KRASG12C IN-19 |
|
|
|
|
|
|
| KRASG12C IN-15 |
|
|
|
|
|
|
| KRASG12D-IN-7 |
|
|
|
|
|
|
| KRASG12D-IN-8 |
|
|
|
|
|
|
| KS-133 |
|
|
|
|
|
98.75% |
| KU004 |
|
|
|
|
|
|
| KZ-02 |
|
|
|
|
|
|
| L 741742 |
|
|
|
|
|
99.28% |
| L 741742 hydrochloride |
|
|
|
|
|
|
| Larixol |
|
|
|
|
|
95.52% |
| Latanoprost acid |
|
|
|
|
|
98.77% |
| Laxiflorin B |
|
|
|
|
|
|
| Laxiflorin B-4 |
|
|
|
|
|
|
| Lazertinib |
|
|
|
|
|
99.87% |
| Lazertinib mesylate |
|
|
|
|
|
99.85% |
| Lazertinib mesylate hydrate |
|
|
|
|
|
|
| LC-MG-10 |
|
|
|
|
|
|
| LC-SF-14 |
|
|
|
|
|
|
| Len-604 |
|
|
|
|
|
|
| Leucic acid |
|
|
|
|
|
98.38% |
| Leukotriene E4-d5 |
|
|
|
|
|
98.5% |
| LHQ766 |
|
|
|
|
|
|
| Licoflavanone |
|
|
|
|
|
|
| Lidocaine |
|
|
|
|
|
|
| LJ-2698 |
|
|
|
|
|
|
| LLS30 |
|
|
|
|
|
|
| LM22B-10 |
|
|
|
|
|
99.92% |
| Lobeglitazone sulfate |
|
|
|
|
|
99.63% |
| Longdaysin |
|
|
|
|
|
99.83% |
| LQEQ-19 (mouse, rat) |
|
|
|
|
|
|
| Lumichrome-d8 |
|
|
|
|
|
|
| LUNA18 |
|
|
|
|
|
99.76% |
| LUT014 |
|
|
|
|
|
97.09% |
| LYP-IN-5 |
|
|
|
|
|
|
| MA191 |
|
|
|
|
|
|
| MAP855 |
|
|
|
|
|
98.37% |
| MAPK-IN-1 |
|
|
|
|
|
98.11% |
| MAPK-IN-3 |
|
|
|
|
|
|
| MAPK-IN-6 |
|
|
|
|
|
|
| MAPK15 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
| Mapk15 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
| Mapk15 Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
| MARY1 |
|
|
|
|
|
|
| MCB-22-174 |
|
|
|
|
|
99.78% |
| MD-3-A45 |
|
|
|
|
|
98.23% |
| MEK1 Derived Peptide Inhibitor 1 |
|
|
|
|
|
|
| Meptyldinocap |
|
|
|
|
|
99.91% |
| Methyl helicterate |
|
|
|
|
|
|
| Methyl protodioscin |
|
|
|
|
|
99.67% |
| Methyllinderone |
|
|
|
|
|
|
| MHJ-627 |
|
|
|
|
|
|
| Mianserin-d3 |
|
|
|
|
|
|
| Migoprotafib |
|
|
|
|
|
98.81% |
| MK-8353 |
|
|
|
|
|
98.13% |
| MK-8353 hydrochloride |
|
|
|
|
|
|
| MK2-IN-5 |
|
|
|
|
|
|
| MK2-IN-5 acetate |
|
|
|
|
|
99.64% |
| ML138 |
|
|
|
|
|
|
| ML191 |
|
|
|
|
|
99.81% |
| ML192 |
|
|
|
|
|
99.70% |
| MO-2097 |
|
|
|
|
|
|
| Molibresib besylate |
|
|
|
|
|
97.04% |
| MptpB-IN-3 |
|
|
|
|
|
|
| MRS2693 ammonium |
|
|
|
|
|
|
| MRS2693 trisodium |
|
|
|
|
|
|
| mSIRK |
|
|
|
|
|
99.54% |
| mSIRK (L9A) |
|
|
|
|
|
|
| MT-125 |
|
|
|
|
|
98.73% |
| MT-125 free base |
|
|
|
|
|
98.67% |
| Multi-target kinase-IN-5 |
|
|
|
|
|
|
| MY-673 |
|
|
|
|
|
98.60% |
| Myrislignan |
|
|
|
|
|
99.53% |
| Myrislignan-13C,d2 |
|
|
|
|
|
|
| N-(p-Coumaroyl) Serotonin |
|
|
|
|
|
99.03% |
| N-(p-Coumaroyl) Serotonin (Standard) |
|
|
|
|
|
|
| N-3-oxo-dodecanoyl-L-homoserine lactone |
|
|
|
|
|
99.88% |
| N-Feruloylserotonin |
|
|
|
|
|
99.93% |
| N-Salicyloyltryptamine |
|
|
|
|
|
96.37% |
| Nε-(Carboxymethyl)-L-lysine |
|
|
|
|
|
95.0% |
| Napyradiomycin B4 |
|
|
|
|
|
|
| Neopterin |
|
|
|
|
|
99.95% |
| NEPP11 |
|
|
|
|
|
|
| Nitrefazole |
|
|
|
|
|
99.44% |
| NLX-219 |
|
|
|
|
|
|
| NMac1 |
|
|
|
|
|
|
| NN3201 |
|
|
|
|
|
99.15% |
| Norkurarinol |
|
|
|
|
|
|
| Nrf2/HO-1 activator 1 |
|
|
|
|
|
|
| Nrf2/HO-1 activator 2 |
|
|
|
|
|
|
| NS-417 free base |
|
|
|
|
|
|
| NT-1 |
|
|
|
|
|
99.40% |
| NY0123 |
|
|
|
|
|
|
| Ombuoside |
|
|
|
|
|
99.68% |
| OP-1118 |
|
|
|
|
|
|
| OR-1855 |
|
|
|
|
|
98.31% |
| Oxypeucedanin |
|
|
|
|
|
99.50% |
| PACAP (1-38), human, ovine, rat |
|
|
|
|
|
99.99% |
| PACAP (1-38), human, ovine, rat TFA |
|
|
|
|
|
|
| PARP1/ERK IN-1 |
|
|
|
|
|
|
| PB1 |
|
|
|
|
|
99.47% |
| PCC0105005 |
|
|
|
|
|
|
| PD 174265 |
|
|
|
|
|
98.35% |
| PD98059 |
|
|
|
|
|
99.27% |
| PDGFRA/CAIX/XII-IN-1 |
|
|
|
|
|
98.10% |
| Pellitorine |
|
|
|
|
|
98.30% |
| Pentadecanoic acid |
|
|
|
|
|
99.92% |
| Peptide E5 |
|
|
|
|
|
|
| Peptide R analogue 10 |
|
|
|
|
|
|
| Peptide R54 acetate |
|
|
|
|
|
99.88% |
| Pestanoid A |
|
|
|
|
|
|
| Pheophytin a |
|
|
|
|
|
80.0% |
| Phloroglucinol |
|
|
|
|
|
99.97% |
| Phoenixin-14 |
|
|
|
|
|
99.28% |
| Phoenixin-14 TFA |
|
|
|
|
|
|
| Phosphocreatine dipotassium |
|
|
|
|
|
|
| Phosphocreatine disodium hydrate |
|
|
|
|
|
99.57% |
| Physcion 8-O-β-D-glucopyranoside |
|
|
|
|
|
99.21% |
| PI3K/AKT/ERK/CREB activator 1 |
|
|
|
|
|
|
| Picrasidine J |
|
|
|
|
|
|
| Piezo1 agonist 1-d2 |
|
|
|
|
|
|
| Pinocembrin 7-O-[3''-O-galloyl-4'',6''-hexahydroxydiphenoyl]-β-D-glucoside |
|
|
|
|
|
98.92% |
| Pipoxolan |
|
|
|
|
|
|
| PLS-123 |
|
|
|
|
|
|
| Pluripotin |
|
|
|
|
|
98.86% |
| Polfurmetinib |
|
|
|
|
|
98.21% |
| Polygalasaponin XXXII |
|
|
|
|
|
|
| POP-3MB |
|
|
|
|
|
|
| PPA24 |
|
|
|
|
|
98.09% |
| PPM-3 |
|
|
|
|
|
98.2% |
| PQ-1 |
|
|
|
|
|
|
| Prexigebersen sodium |
|
|
|
|
|
98.95% |
| Prexigebersen sodium scrambled negative control |
|
|
|
|
|
|
| Prolylserine |
|
|
|
|
|
|
| Prosaptide Tx14(A) TFA |
|
|
|
|
|
99.81% |
| Prostaglandin A2 |
|
|
|
|
|
99.9% |
| PROTAC ALK degrader-4 |
|
|
|
|
|
|
| PROTAC Bcl-xL degrader-4 |
|
|
|
|
|
|
| PROTAC CB1R Degrader-1 |
|
|
|
|
|
|
| PROTAC ERK5 degrader-1 |
|
|
|
|
|
99.58% |
| PROTAC FAK degrader 2 |
|
|
|
|
|
|
| PROTAC FLT-3 degrader 1 |
|
|
|
|
|
98.26% |
| PROTAC FLT3/CHK1 Degrader-1 |
|
|
|
|
|
|
| PROTAC HER2 degrader-1 |
|
|
|
|
|
98.0% |
| PROTAC HPK1 Degrader-5 |
|
|
|
|
|
|
| PROTAC K-Ras Degrader-5 |
|
|
|
|
|
95.04% |
| PROTAC KRAS G12D degrader 1 |
|
|
|
|
|
98.32% |
| PROTAC MEK1 Degrader-1 |
|
|
|
|
|
98.03% |
| PROTAC RET Degrader 2 |
|
|
|
|
|
|
| Protegrin-1 |
|
|
|
|
|
99.87% |
| PT-262 |
|
|
|
|
|
99.21% |
| Pyridoxal 5'-phosphate monohydrate |
|
|
|
|
|
98.0% |
| Q-Peptide |
|
|
|
|
|
99.46% |
| Quin-C7 |
|
|
|
|
|
99.76% |
| Quinalizarin |
|
|
|
|
|
97.23% |
| Rafutrombopag |
|
|
|
|
|
95.29% |
| RANKL-IN-1 |
|
|
|
|
|
|
| Rapastinel acetate |
|
|
|
|
|
|
| Rapastinel Trifluoroacetate |
|
|
|
|
|
98.0% |
| Ravoxertinib |
|
|
|
|
|
99.74% |
| Ravoxertinib |
|
|
|
|
|
|
| Ravoxertinib hydrochloride |
|
|
|
|
|
99.44% |
| Raxofelast |
|
|
|
|
|
|
| RDN2150 |
|
|
|
|
|
|
| RDN2150 TFA |
|
|
|
|
|
99.80% |
| Recoflavone |
|
|
|
|
|
98.0% |
| rel-Latanoprost acid |
|
|
|
|
|
|
| Resolvin D5 |
|
|
|
|
|
98.3% |
| Resomelagon methanesulfonate |
|
|
|
|
|
|
| Revaprazan hydrochloride |
|
|
|
|
|
99.98% |
| Rineterkib |
|
|
|
|
|
98.79% |
| Rineterkib hydrochloride |
|
|
|
|
|
99.81% |
| RK-682 |
|
|
|
|
|
|
| RK-682 hemicalcium |
|
|
|
|
|
|
| RLX-33 |
|
|
|
|
|
99.79% |
| RM-046 |
|
|
|
|
|
|
| RMC-4998 |
|
|
|
|
|
99.31% |
| RMC-4998 formic |
|
|
|
|
|
|
| RMC-4998 TFA |
|
|
|
|
|
99.02% |
| RMC-7977 |
|
|
|
|
|
99.48% |
| RNK08954 |
|
|
|
|
|
|
| RO5068760 |
|
|
|
|
|
|
| ROCK-IN-5 |
|
|
|
|
|
99.52% |
| RWT9996 |
|
|
|
|
|
|
| SAIT-301 |
|
|
|
|
|
|
| Sappanone A |
|
|
|
|
|
99.87% |
| Satratoxin H |
|
|
|
|
|
99.7% |
| SBI-810 |
|
|
|
|
|
98.25% |
| SBI-810 hydrochloride |
|
|
|
|
|
99.55% |
| SCH772984 |
|
|
|
|
|
99.83% |
| SDUY127 |
|
|
|
|
|
|
| Senkyunolide I |
|
|
|
|
|
99.37% |
| Serum thymic factor |
|
|
|
|
|
98.09% |
| Serum thymic factor acetate |
|
|
|
|
|
99.62% |
| Setidegrasib |
|
|
|
|
|
99.42% |
| SEW2871 |
|
|
|
|
|
99.88% |
| SF-3-030 |
|
|
|
|
|
|
| SF-9-2 |
|
|
|
|
|
|
| SHP1-IN-2 |
|
|
|
|
|
|
| SHP2 inhibitor LY6 |
|
|
|
|
|
|
| SHP2-IN-23 |
|
|
|
|
|
|
| SHP2-IN-31 |
|
|
|
|
|
|
| SHP2-IN-38 |
|
|
|
|
|
|
| SHP2-IN-44 |
|
|
|
|
|
|
| SHP2-IN-47 |
|
|
|
|
|
|
| SHR-A1403 Antibody |
|
|
|
|
|
|
| SHR2415 |
|
|
|
|
|
98.63% |
| SHY-855 |
|
|
|
|
|
98.54% |
| SHY-867 |
|
|
|
|
|
|
| Sialorphin |
|
|
|
|
|
|
| Sialorphin TFA |
|
|
|
|
|
|
| SIJ1777 |
|
|
|
|
|
|
| SIRT6-IN-3 |
|
|
|
|
|
98.19% |
| Sitagliptin hydrochloride |
|
|
|
|
|
|
| Sitagliptin-d4 |
|
|
|
|
|
|
| Sitagliptin-d6 |
|
|
|
|
|
|
| SJ-C1044 |
|
|
|
|
|
98.63% |
| SKI2496 |
|
|
|
|
|
|
| SKLB-D18 |
|
|
|
|
|
98.06% |
| SL43 |
|
|
|
|
|
|
| SM-17 |
|
|
|
|
|
96.98% |
| SMU-037 |
|
|
|
|
|
|
| SMU-14a |
|
|
|
|
|
|
| SMU-L11-R |
|
|
|
|
|
|
| SNX-7081 |
|
|
|
|
|
|
| SOS1 activator 2 |
|
|
|
|
|
|
| SOS1-IN-18 |
|
|
|
|
|
|
| SPOP-IN-1 |
|
|
|
|
|
99.71% |
| SS-3091 |
|
|
|
|
|
|
| SST0116CL1 free base |
|
|
|
|
|
|
| STE-MEK1(13) |
|
|
|
|
|
|
| STK899704 |
|
|
|
|
|
|
| Strictinin |
|
|
|
|
|
97.15% |
| STX-721 |
|
|
|
|
|
98.25% |
| STX107 |
|
|
|
|
|
|
| Sugiol |
|
|
|
|
|
99.88% |
| Sulforaphene |
|
|
|
|
|
99.78% |
| SY-LB-35 |
|
|
|
|
|
99.54% |
| TAT-MEK1 |
|
|
|
|
|
|
| Tau Protein Phosphorylation-IN-1 |
|
|
|
|
|
|
| TCB-32 |
|
|
|
|
|
|
| TCB-32 hydrochloride |
|
|
|
|
|
97.69% |
| Temuterkib |
|
|
|
|
|
99.93% |
| Tenuifoliside A |
|
|
|
|
|
98.09% |
| TERT activator-1 |
|
|
|
|
|
99.91% |
| Theophylline-platinum(IV) prodrug-1 |
|
|
|
|
|
|
| Thymus Factor |
|
|
|
|
|
|
| Tizaterkib |
|
|
|
|
|
99.09% |
| Tizaterkib hexanedioic acid |
|
|
|
|
|
|
| TriDAP |
|
|
|
|
|
|
| TriDAP dihydrochloride |
|
|
|
|
|
98.65% |
| Trilinolein |
|
|
|
|
|
98.0% |
| Trilinolein-13C54 |
|
|
|
|
|
|
| Trilinolein-d5 |
|
|
|
|
|
|
| Triphenyl phosphate-d15 |
|
|
|
|
|
99.55% |
| TRK-IN-30 |
|
|
|
|
|
|
| TRV055 |
|
|
|
|
|
99.47% |
| TX2-121-1 |
|
|
|
|
|
|
| Tyrosine kinase-IN-11 |
|
|
|
|
|
98.75% |
| UBX-382 |
|
|
|
|
|
96.20% |
| UC-857993 |
|
|
|
|
|
|
| UFP-512 |
|
|
|
|
|
|
| Ulixertinib |
|
|
|
|
|
99.92% |
| Ulixertinib hydrochloride |
|
|
|
|
|
99.89% |
| Umckalin |
|
|
|
|
|
|
| UNC1062 |
|
|
|
|
|
98.92% |
| UNC1666 |
|
|
|
|
|
|
| Urocortin II, human |
|
|
|
|
|
99.95% |
| Urocortin II, human acetate |
|
|
|
|
|
99.61% |
| Urocortin II, human TFA |
|
|
|
|
|
|
| VEGFR2-IN-84 |
|
|
|
|
|
|
| Vitisin A |
|
|
|
|
|
96% |
| VS1150 |
|
|
|
|
|
|
| VSLRGDTRG |
|
|
|
|
|
|
| VSLRGDTRG acetate |
|
|
|
|
|
99.38% |
| VX-11e |
|
|
|
|
|
98.94% |
| WB-308 |
|
|
|
|
|
|
| WH23 |
|
|
|
|
|
|
| Wighteone |
|
|
|
|
|
98.71% |
| Withanolide B |
|
|
|
|
|
98.52% |
| Wnt/β-catenin-IN-6 |
|
|
|
|
|
98.34% |
| WQ-C-401 |
|
|
|
|
|
99.41% |
| WZH-17-002 |
|
|
|
|
|
|
| X-370 |
|
|
|
|
|
|
| Xaliproden free base |
|
|
|
|
|
|
| Xaliproden hydrochloride |
|
|
|
|
|
98.40% |
| XMD-17-51 TFA |
|
|
|
|
|
99.46% |
| XMD17-109 |
|
|
|
|
|
99.14% |
| XMD8-92 |
|
|
|
|
|
99.48% |
| XMU-MP-2 |
|
|
|
|
|
99.29% |
| YK-8S |
|
|
|
|
|
|
| YLL545 |
|
|
|
|
|
|
| Yoda 1 |
|
|
|
|
|
99.97% |
| YS110 |
|
|
|
|
|
99.75% |
| Z52 |
|
|
|
|
|
95.76% |
| ZEB85 |
|
|
|
|
|
96.3985% |
| ZINC-1000507824 |
|
|
|
|
|
|
| ZINC12409120 |
|
|
|
|
|
99.95% |
| ZSH-2117 |
|
|
|
|
|
|
| ZY-444 |
|
|
|
|
|
99.51% |
| α,δ-NAG |
|
|
|
|
|
|
| α-Amyrin |
|
|
|
|
|
99.99% |
| α4β1 antagonist-1 |
|
|
|
|
|
|
| β-Neo-Endorphin |
|
|
|
|
|
98.97% |
| β-Patchoulene |
|
|
|
|
|
|
| β-Glycerophosphate disodium salt hydrate |
|
|
|
|
|
99.92% |
| Gamma-Linolenic acid |
|
|
|
|
|
99.80% |
| Notoginsenoside Ft1 |
|
|
|
|
|
99.49% |
| Notoginsenoside R2 |
|
|
|
|
|
99.80% |
| Trifolirhizin |
|
|
|
|
|
98.37% |
| Deltonin |
|
|
|
|
|
99.93% |
| Paeonolide |
|
|
|
|
|
99.89% |
| Lactose |
|
|
|
|
|
98.0% |
| β-Glycerophosphate disodium salt pentahydrate |
|
|
|
|
|
99.99% |
| Lumichrome |
|
|
|
|
|
99.84% |
| Crebanine |
|
|
|
|
|
99.83% |
| Perfluoroundecanoic acid-13C7 |
|
|
|
|
|
|
| Perfluoroundecanoic acid |
|
|
|
|
|
99.85% |
| 6:2 Fluorotelomer alcohol |
|
|
|
|
|
99.96% |
| Hexachlorobenzene |
|
|
|
|
|
98.82% |
| Lidocaine-d10 |
|
|
|
|
|
98.89% |
| N-Oxide Lidocaine-d10 |
|
|
|
|
|
|
| Lidocaine (Standard) |
|
|
|
|
|
99.97% |
| Lidocaine-d6 |
|
|
|
|
|
|
| Lidocaine |
|
|
|
|
|
99.96% |
| Ononin |
|
|
|
|
|
99.97% |
| Flavokawain A |
|
|
|
|
|
99.73% |
| Cavidine |
|
|
|
|
|
|
| Corynoxeine |
|
|
|
|
|
99.97% |
| Demethylwedelolactone |
|
|
|
|
|
99.89% |
| Bicyclol |
|
|
|
|
|
99.91% |
| trans-Zeatin |
|
|
|
|
|
99.77% |
| trans-Zeatin-d5 |
|
|
|
|
|
99.2% |
| Elaidic acid |
|
|
|
|
|
99.81% |
| Honokiol |
|
|
|
|
|
99.85% |
| Cafestol |
|
|
|
|
|
99.20% |
| Ganglioside GM1 |
|
|
|
|
|
99% |
| Orcinol |
|
|
|
|
|
99.97% |
| Erlotinib (Standard) |
|
|
|
|
|
99.97% |
| Erlotinib-13C6 |
|
|
|
|
|
|
| Erlotinib-d6 |
|
|
|
|
|
99.83% |
| Erlotinib-d8 |
|
|
|
|
|
|
| Erlotinib |
|
|
|
|
|
99.96% |
| Erlotinib mesylate |
|
|
|
|
|
|
| Hypothemycin |
|
|
|
|
|
98.0% |
| Microhelenin C |
|
|
|
|
|
99.55% |
| Urolithin B |
|
|
|
|
|
99.85% |
| Urea |
|
|
|
|
|
99.84% |
| Urea-13C,15N |
|
|
|
|
|
|
| Cornuside |
|
|
|
|
|
99.99% |
| Peramivir |
|
|
|
|
|
99.94% |
| Peramivir trihydrate |
|
|
|
|
|
98.30% |
| Isomaltulose monohydrate |
|
|
|
|
|
|
| Patritumab |
|
|
|
|
|
99.28% |
| Pamoic acid |
|
|
|
|
|
99.69% |
| Isoscopoletin |
|
|
|
|
|
99.92% |
| Isofraxidin |
|
|
|
|
|
99.94% |
| Isosinensetin |
|
|
|
|
|
99.90% |
| Isosilybin A |
|
|
|
|
|
99.63% |
| Isorhamnetin 3-O-galactoside |
|
|
|
|
|
99.64% |
| Enniatin A1 |
|
|
|
|
|
|
| Enniatin A1-13C35 |
|
|
|
|
|
|
| Gomisin D |
|
|
|
|
|
99.56% |
| Avicularin |
|
|
|
|
|
99.80% |
| Dinitramine |
|
|
|
|
|
|
| Cantharidic acid |
|
|
|
|
|
|
| Acenocoumarol-d4 |
|
|
|
|
|
|
| Acenocoumarol-d5 |
|
|
|
|
|
|
| Acenocoumarol |
|
|
|
|
|
99.17% |
| Neoandrographolide |
|
|
|
|
|
99.41% |
| Flavanone |
|
|
|
|
|
99.73% |
| Trimebutine |
|
|
|
|
|
99.42% |
| Trimebutine (Standard) |
|
|
|
|
|
98% |
| Trimebutine-d5 fumarate |
|
|
|
|
|
|
| Trimebutine-d3 hydrochloride |
|
|
|
|
|
|
| Tinlorafenib |
|
|
|
|
|
98.21% |
| Magnolin |
|
|
|
|
|
99.98% |
| Armepavine |
|
|
|
|
|
99.19% |
| Myricetin 3-O-galactoside |
|
|
|
|
|
99.27% |
| Citropten |
|
|
|
|
|
99.69% |
| Pectolinarigenin |
|
|
|
|
|
99.98% |
| Gardenin A |
|
|
|
|
|
97.61% |
| Roburic acid |
|
|
|
|
|
99.93% |
| Gliquidone |
|
|
|
|
|
99.93% |
| Sanggenon C |
|
|
|
|
|
98.46% |
| Platycodin D3 |
|
|
|
|
|
98.91% |
| Pamoic acid disodium |
|
|
|
|
|
99.86% |
| Sophocarpine |
|
|
|
|
|
99.85% |
| Sophocarpine monohydrate |
|
|
|
|
|
99.91% |
| Propoxur-d3 |
|
|
|
|
|
|
| Propoxur-d7 |
|
|
|
|
|
|
| Propoxur |
|
|
|
|
|
99.43% |
| Flurbiprofen axetil |
|
|
|
|
|
99.34% |
| Aminoguanidine hydrochloride |
|
|
|
|
|
98.0% |
| Nitidine chloride |
|
|
|
|
|
99.82% |
| Lanthanum(Ⅲ) chloride |
|
|
|
|
|
99.99% |
| Salbutamol-d3 |
|
|
|
|
|
98.59% |
| Salbutamol-d4 |
|
|
|
|
|
|
| Salbutamol-d9 |
|
|
|
|
|
98.00% |
| Salbutamol-d9 acetate |
|
|
|
|
|
99.48% |
| Salbutamol |
|
|
|
|
|
99.53% |
| Salbutamol adipate |
|
|
|
|
|
|
| Alisol F |
|
|
|
|
|
99.89% |
| Lobeglitazone |
|
|
|
|
|
96.18% |
| Rafutrombopag (tautomerism) |
|
|
|
|
|
98.33% |
| Lysophosphatidylcholines |
|
|
|
|
|
99.9% |
| Tauroursodeoxycholate-d5 |
|
|
|
|
|
|
| Tauroursodeoxycholate-d4-1 |
|
|
|
|
|
|
| Tauroursodeoxycholate-d4 |
|
|
|
|
|
|
| Tauroursodeoxycholate |
|
|
|
|
|
99.90% |
| Tauroursodeoxycholate-d4 sodium |
|
|
|
|
|
|
| Tauroursodeoxycholate sodium |
|
|
|
|
|
98.40% |
| TBHQ-d12 |
|
|
|
|
|
|
| TBHQ |
|
|
|
|
|
99.86% |
| Vaccarin |
|
|
|
|
|
99.05% |
| Phellopterin |
|
|
|
|
|
99.94% |
| Revaprazan |
|
|
|
|
|
|
| Glycinexylidide |
|
|
|
|
|
95.06% |
| Kansuinine B |
|
|
|
|
|
99.0% |
| Methylthiouracil |
|
|
|
|
|
98.0% |
| Sorafenib tosylate |
|
|
|
|
|
99.98% |
| Byakangelicol |
|
|
|
|
|
98.66% |
| Atractylenolide II |
|
|
|
|
|
99.89% |
| Bilobetin |
|
|
|
|
|
99.71% |
| Lidocaine hydrochloride |
|
|
|
|
|
99.84% |
| Lidocaine-d10 hydrochloride |
|
|
|
|
|
99.55% |
| Lidocaine-d6 hydrochloride |
|
|
|
|
|
|
| Lidocaine hydrochloride hydrate |
|
|
|
|
|
99.80% |
| Desipramine-d3 |
|
|
|
|
|
|
| Desipramine-d4 |
|
|
|
|
|
98.93% |
| Desipramine hydrochloride |
|
|
|
|
|
99.76% |
| Erlotinib Hydrochloride |
|
|
|
|
|
99.94% |
| Erlotinib Hydrochloride (Standard) |
|
|
|
|
|
99.73% |
| Erlotinib-d6 hydrochloride |
|
|
|
|
|
98.13% |
| Erlotinib-13C6 hydrochloride |
|
|
|
|
|
|
| Penehyclidine hydrochloride |
|
|
|
|
|
99.2% |
| Mianserin hydrochloride |
|
|
|
|
|
99.95% |
| Mianserin-d3 (hydrochloride) |
|
|
|
|
|
97.51% |
| Maprotiline hydrochloride |
|
|
|
|
|
99.84% |
| Salbutamol hemisulfate |
|
|
|
|
|
98.0% |
| Chondroitin sulfate (from chicken) |
|
|
|
|
|
99.61% |
| Triphenyl phosphate |
|
|
|
|
|
98.0% |
| Pyridoxal Phosphate-d3 |
|
|
|
|
|
98.01% |
| Pyridoxal phosphate |
|
|
|
|
|
99.95% |
| Pyridoxal 5'-phosphate hydrate |
|
|
|
|
|
99.76% |
| Phosphocreatine |
|
|
|
|
|
99.60% |
| Phosphocreatine disodium |
|
|
|
|
|
98.0% |
| Sitagliptin phosphate |
|
|
|
|
|
99.88% |
| Sitagliptin-d4 phosphate |
|
|
|
|
|
99.48% |
| Sitagliptin phosphate monohydrate |
|
|
|
|
|
99.83% |
| Raddeanin A |
|
|
|
|
|
98.68% |
| Mianserin |
|
|
|
|
|
99.42% |
| Sorafenib |
|
|
|
|
|
99.84% |
| Plasmin, Human plasma |
|
|
|
|
|
|
| Viridicatol |
|
|
|
|
|
99.93% |
| Gypenoside L |
|
|
|
|
|
99.89% |
| Vicenin 3 |
|
|
|
|
|
99.90% |
| Rohitukine |
|
|
|
|
|
|
| Mogroside III-E |
|
|
|
|
|
99.30% |
| Mogrol |
|
|
|
|
|
99.76% |
| Poly-L-ornithine hydrobromide (MW 5000-15000) |
|
|
|
|
|
|
| Cinnamyl Alcohol |
|
|
|
|
|
98.58% |
| Cinnamyl Alcohol-d5 |
|
|
|
|
|
|
| Cinnamyl Alcohol-d9 |
|
|
|
|
|
|
| Myristicin |
|
|
|
|
|
99.54% |
| Lipoteichoic acid |
|
|
|
|
|
|
| Keracyanin chloride |
|
|
|
|
|
99.90% |
| Benzanthrone |
|
|
|
|
|
99.69% |
| Pachymic acid |
|
|
|
|
|
99.94% |
| Piperlongumine |
|
|
|
|
|
99.86% |
| Fenoprofen |
|
|
|
|
|
99.70% |
| Fenoprofen-13C6 sodium hydrate |
|
|
|
|
|
|
| Gluconate Calcium |
|
|
|
|
|
98.0% |
| Gluconate sodium |
|
|
|
|
|
≥98.0% |
| Gluconate-1-13C sodium |
|
|
|
|
|
99.89% |
| Gluconate-d6 sodium |
|
|
|
|
|
|
| Cucurbitacin IIa |
|
|
|
|
|
99.90% |
| Gambogic amide |
|
|
|
|
|
95.76% |
| Hellebrigenin |
|
|
|
|
|
99.69% |
| Fucoxanthin |
|
|
|
|
|
99.54% |
| Chicanine |
|
|
|
|
|
99.96% |
| Sitagliptin-d4 hydrochloride |
|
|
|
|
|
99.22% |
| Sitagliptin |
|
|
|
|
|
99.94% |
| Simetryn |
|
|
|
|
|
99.75% |
| Peiminine |
|
|
|
|
|
99.89% |
| Asperulosidic Acid |
|
|
|
|
|
99.63% |
| Daporinad |
|
|
|
|
|
99.91% |
| Daporinad hydrochloride |
|
|
|
|
|
|
| Ergosterol peroxide |
|
|
|
|
|
99.57% |
| Varenicline Tartrate |
|
|
|
|
|
99.96% |
| Jujuboside B |
|
|
|
|
|
99.92% |
| Physalin B |
|
|
|
|
|
97.20% |
| Eupalinolide A |
|
|
|
|
|
99.92% |
| Enniatin B1 |
|
|
|
|
|
99.33% |
| Enniatin B |
|
|
|
|
|
99.86% |
| Apomorphine (Standard) |
|
|
|
|
|
|
| Apomorphine |
|
|
|
|
|
99.19% |
| Apomorphine hydrochloride hemihydrate |
|
|
|
|
|
99.85% |
| Bullatine A |
|
|
|
|
|
98.0% |
| Rapastinel |
|
|
|
|
|
99.78% |
| Fenoprofen Calcium |
|
|
|
|
|
|
| Fenoprofen Calcium hydrate |
|
|
|
|
|
99.52% |
| Gondoic acid |
|
|
|
|
|
95.0% |
| Citronellol |
|
|
|
|
|
98.40% |
| Citronellol-d3 |
|
|
|
|
|
|
| Maprotiline |
|
|
|
|
|
|
| Trimebutine maleate |
|
|
|
|
|
99.66% |
| Trimebutine maleate (Standard) |
|
|
|
|
|
98% |
| Ophiopogonin D |
|
|
|
|
|
99.80% |
| Astragaloside IV |
|
|
|
|
|
99.93% |
| Methylnissolin |
|
|
|
|
|
99.92% |
| Hecogenin acetate |
|
|
|
|
|
98.57% |
| Loureirin B |
|
|
|
|
|
99.96% |